FTSE 100
|
10 896,40
|
17,02
|
0,16 %
|
Analysen zu FTSE 100-Werten
| 30.07.26 | BAT Underperform | RBC Capital Markets | |
| 30.07.26 | Rio Tinto Neutral | UBS AG | |
| 30.07.26 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 30.07.26 | Rolls-Royce Overweight | JP Morgan Chase & Co. | |
| 30.07.26 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.07.26 | Rio Tinto Underperform | RBC Capital Markets | |
| 29.07.26 | Unilever Kaufen | DZ BANK | |
| 29.07.26 | Rio Tinto Underperform | RBC Capital Markets | |
| 29.07.26 | Unilever Sell | UBS AG | |
| 29.07.26 | Unilever Sell | UBS AG | |
| 29.07.26 | Unilever Hold | Deutsche Bank AG | |
| 29.07.26 | GSK Halten | DZ BANK | |
| 29.07.26 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 29.07.26 | Rio Tinto Neutral | JP Morgan Chase & Co. | |
| 29.07.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 29.07.26 | AstraZeneca Outperform | Bernstein Research | |
| 29.07.26 | Barclays Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 29.07.26 | Barclays Overweight | JP Morgan Chase & Co. | |
| 29.07.26 | Diageo Hold | Deutsche Bank AG | |
| 28.07.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 28.07.26 | Unilever Sector Perform | RBC Capital Markets | |
| 28.07.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 28.07.26 | GSK Outperform | Bernstein Research | |
| 28.07.26 | GSK Buy | Jefferies & Company Inc. | |
| 28.07.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 28.07.26 | Unilever Outperform | Bernstein Research | |
| 28.07.26 | Unilever Sector Perform | RBC Capital Markets | |
| 28.07.26 | Unilever Hold | Deutsche Bank AG | |
| 28.07.26 | AstraZeneca Kaufen | DZ BANK | |
| 28.07.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.07.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 28.07.26 | Vodafone Group Buy | Deutsche Bank AG | |
| 28.07.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 28.07.26 | Vodafone Group Sell | UBS AG | |
| 28.07.26 | Unilever Sell | UBS AG | |
| 28.07.26 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 28.07.26 | AstraZeneca Buy | UBS AG | |
| 28.07.26 | Diageo Neutral | UBS AG | |
| 28.07.26 | Barclays Buy | Jefferies & Company Inc. | |
| 28.07.26 | Barclays Outperform | RBC Capital Markets |